Althea Lai

Apr 27, 2023 | citoday.com | David Meier |Stephanie Sellers |Hacina Gill |Althea Lai |Geoffrey W. Payne

Over the past 20 years, transcatheter aortic valve replacement (TAVR) with transcatheter heart valves (THVs) has proven to be a safe and effective alternative to surgical aortic valve replacement (SAVR) with bioprosthetic surgical heart valves (SHVs) or mechanical prostheses.1 While historically indicated for patients at high surgical risk, improvements in valve durability and design, the growing number of experienced operators, and consideration for patient preference have led to a shift in...